Dimensional Fund Advisors
OCUL icon

Dimensional Fund Advisors’s Ocular Therapeutix OCUL Stock Holding History

Dimensional Fund Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
2,783,367
+2,133,611
+328% +$19.3M 0.01% 1899
2026
Q1 		$5.49M Buy
+649,756
New +$6.19M ﹤0.01% 2468
2024
Q1 		– Sell
-12,389
Closed -$55.3K – 3422
2023
Q4 		$55.3K Hold
12,389
– – ﹤0.01% 3341
2023
Q3 		$38.9K Sell
12,389
-11,930
-49% -$48.8K ﹤0.01% 3399
2023
Q2 		$125K Hold
24,319
– – ﹤0.01% 3299
2023
Q1 		$128K Buy
+24,319
New +$115K ﹤0.01% 3273
2022
Q3 		$607K Buy
146,122
+38,310
+36% +$193K ﹤0.01% 2998
2022
Q2 		$434K Buy
107,812
+91,089
+545% +$344K ﹤0.01% 3095
2022
Q1 		$83K Hold
16,723
– – ﹤0.01% 3413
2021
Q4 		$117K Buy
+16,723
New +$130K ﹤0.01% 3415
2019
Q4 		– Sell
-11,423
Closed -$35K – 3400
2019
Q3 		$35K Hold
11,423
– – ﹤0.01% 3401
2019
Q2 		$50K Sell
11,423
-12,408
-52% -$45.9K ﹤0.01% 3427
2019
Q1 		$95K Hold
23,831
– – ﹤0.01% 3379
2018
Q4 		$95K Sell
23,831
-5,259
-18% -$29K ﹤0.01% 3360
2018
Q3 		$200K Buy
+29,090
New +$183K ﹤0.01% 3308
2018
Q1 		– Sell
-39,664
Closed -$177K – 3355
2017
Q4 		$177K Hold
39,664
– – ﹤0.01% 3235
2017
Q3 		$245K Buy
+39,664
New +$255K ﹤0.01% 3193

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's OCUL Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Ocular Therapeutix (OCUL) stake by 328% in Q2 2026, buying an estimated $19.3M and bringing the position to 2,783,367 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #1899.

Dimensional Fund Advisors first reported a position in OCUL in Q3 2017 and has held it in 17 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Dimensional Fund Advisors held 2,783,367 shares of Ocular Therapeutix worth $27.3M as of Q2 2026.
  • Dimensional Fund Advisors bought 2,133,611 Ocular Therapeutix shares in Q2 2026, an estimated $19.3M.
  • Ocular Therapeutix made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1899 holding.
  • Dimensional Fund Advisors first reported a position in Ocular Therapeutix in Q3 2017 and has held it in 17 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.